Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Microenvironmental determinants of ductal carcinoma in situ (DCIS) progression to invasive breast cancer

FY 2020-21

Summary
Ductal carcinoma in situ (DCIS) is a precursor to breast cancer, however, only ~50% of women with DCIS develop breast cancer. With the introduction of early screening for breast cancer, more and more women are being diagnosed with DCIS and aggressively treated with surgery regardless if their condition would have developed into breast cancer or not. In other words, ~50% of women may be receiving treatment they do not need, reducing their quality of life. There is a need to better understand how DCIS develops into breast cancer and identify characteristics, also known as biomarkers, that indicate if treatment is needed. Previous efforts to identify biomarkers have focused on tumour cells. However, a tumour is not only made up of tumour cells but instead also includes normal cells and immune cells, among others. The accumulation of cells can restrict access to important nutrients, like oxygen. My research focuses on understanding how the environment of a tumour - the nearby immune cells and the ability of the tumour to access oxygen - can dictate if DCIS will progress to breast cancer. I will use the knowledge acquired in this study to build biomarkers that can predict which women with DCIS should be treated and which would be better off being actively monitored.
Program
Banting Postdoctoral Fellowship Program
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
436093
Name
Houlahan Kathleen E
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Microenvironmental determinants of ductal carcinoma in situ (DCIS) progression to invasive breast cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Biomarker Development; Breast Cancer; Ductal Carcinoma In Situ; Hypoxia; Immunoediting; Tumour Evolution
Abstract
Ductal carcinoma in situ (DCIS) is a precursor to breast cancer, however, only ~50% of women with DCIS develop breast cancer. With the introduction of early screening for breast cancer, more and more women are being diagnosed with DCIS and aggressively treated with surgery regardless if their condition would have developed into breast cancer or not. In other words, ~50% of women may be receiving treatment they do not need, reducing their quality of life. There is a need to better understand how DCIS develops into breast cancer and identify characteristics, also known as biomarkers, that indicate if treatment is needed. Previous efforts to identify biomarkers have focused on tumour cells. However, a tumour is not only made up of tumour cells but instead also includes normal cells and immune cells, among others. The accumulation of cells can restrict access to important nutrients, like oxygen. My research focuses on understanding how the environment of a tumour - the nearby immune cells and the ability of the tumour to access oxygen - can dictate if DCIS will progress to breast cancer. I will use the knowledge acquired in this study to build biomarkers that can predict which women with DCIS should be treated and which would be better off being actively monitored.
Competitiondate
202010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Houlahan, Kathleen E
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~